Skip to content

HCV viral load levels during treatment and speed of decline do not predict cure with interferon-free therapy

David Wyles presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Daily PrEP leads to better adherence and protective drug levels in women

High treatment failure rate among Thai children switching to second-line ART

Annual CD4 count monitoring may be sufficient for people doing well on HIV treatment

Newly adopted risk behaviours predict HIV infections in Portuguese gay men

High-dose rifampicin may shorten time to TB clearance

Martin Boeree presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Women in PrEP trial feared they would have to leave study if they reported low adherence

Opioid substitution treatment increases chances that people who inject drugs will have good adherence to HIV therapy

Global hepatitis B epidemic treatable at cost of just $36 per patient per year